| Structure of MERS-CoV spike receptor-binding domain complexed with human receptor DPP4 N Wang, X Shi, L Jiang, S Zhang, D Wang, P Tong, D Guo, L Fu, Y Cui, ... Cell research 23 (8), 986-993, 2013 | 833 | 2013 |
| Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant J Zhang, T Xiao, Y Cai, CL Lavine, H Peng, H Zhu, K Anand, P Tong, ... Science 374 (6573), 1353-1360, 2021 | 274 | 2021 |
| Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants Y Cai, J Zhang, T Xiao, CL Lavine, S Rawson, H Peng, H Zhu, K Anand, ... Science 373 (6555), 642-648, 2021 | 224 | 2021 |
| Quick COVID-19 healers sustain anti-SARS-CoV-2 antibody production Y Chen, A Zuiani, S Fischinger, J Mullur, C Atyeo, M Travers, FJN Lelis, ... Cell 183 (6), 1496-1507. e16, 2020 | 193 | 2020 |
| Structural and functional impact by SARS-CoV-2 Omicron spike mutations J Zhang, Y Cai, CL Lavine, H Peng, H Zhu, K Anand, P Tong, A Gautam, ... Cell reports 39 (4), 2022 | 107 | 2022 |
| Memory B cell repertoire for recognition of evolving SARS-CoV-2 spike Cell 184, 1-12, 2021 | 101* | 2021 |
| HIV-1 gp41 core with exposed membrane-proximal external region inducing broad HIV-1 neutralizing antibodies J Wang, P Tong, L Lu, L Zhou, L Xu, S Jiang, Y Chen PloS one 6 (3), e18233, 2011 | 53 | 2011 |
| Molecular mechanisms of IgE class switch recombination P Tong, DR Wesemann IgE antibodies: generation and function, 21-37, 2015 | 46 | 2015 |
| Immune recall improves antibody durability and breadth to SARS-CoV-2 variants Y Chen, P Tong, N Whiteman, A Sanjari Moghaddam, M Zarghami, ... Science Immunology 7 (78), eabp8328, 2022 | 41 | 2022 |
| Stochasticity enables BCR-independent germinal center initiation and antibody affinity maturation J Silver, T Zuo, N Chaudhary, R Kumari, P Tong, S Giguere, A Granato, ... Journal of Experimental Medicine 215 (1), 77-90, 2018 | 38 | 2018 |
| RNAe: an effective method for targeted protein translation enhancement by artificial non-coding RNA with SINEB2 repeat Y Yao, S Jin, H Long, Y Yu, Z Zhang, G Cheng, C Xu, Y Ding, Q Guan, ... Nucleic acids research 43 (9), e58-e58, 2015 | 38 | 2015 |
| Dissecting strategies to tune the therapeutic potential of SARS-CoV-2–specific monoclonal antibody CR3022 C Atyeo, MD Slein, S Fischinger, J Burke, A Schäfer, SR Leist, ... JCI insight 6 (1), 2021 | 36 | 2021 |
| HIV-1 variants with a single-point mutation in the gp41 pocket region exhibiting different susceptibility to HIV fusion inhibitors with pocket-or membrane-binding domain L Lu, P Tong, X Yu, C Pan, P Zou, YH Chen, S Jiang Biochimica Et Biophysica Acta (BBA)-Biomembranes 1818 (12), 2950-2957, 2012 | 36 | 2012 |
| An engineered HIV-1 gp41 trimeric coiled coil with increased stability and anti-HIV-1 activity: implication for developing anti-HIV microbicides P Tong, Z Lu, X Chen, Q Wang, F Yu, P Zou, X Yu, Y Li, L Lu, YH Chen, ... Journal of Antimicrobial Chemotherapy 68 (11), 2533-2544, 2013 | 34 | 2013 |
| Antibodies induced by ancestral SARS-CoV-2 strain can cross-neutralize variants from Alpha to Omicron BA.1 IANWWPEITOLALISMLGAMDKYOOAGDRWANDSC HARRISON Science Immunology, 2022 | 28 | 2022 |
| Mutations of Gln64 in the HIV-1 gp41 N-terminal heptad repeat render viruses resistant to peptide HIV fusion inhibitors targeting the gp41 pocket X Yu, L Lu, L Cai, P Tong, S Tan, P Zou, F Meng, Y Chen, S Jiang Journal of virology 86 (1), 589-593, 2012 | 26 | 2012 |
| IgH isotype-specific B cell receptor expression influences B cell fate P Tong, A Granato, T Zuo, N Chaudhary, A Zuiani, SS Han, R Donthula, ... Proceedings of the National Academy of Sciences 114 (40), E8411-E8420, 2017 | 25 | 2017 |
| Differential antibody dynamics to SARS-CoV-2 infection and vaccination Y Chen, P Tong, NB Whiteman, AS Moghaddam, A Zuiani, S Habibi, ... bioRxiv, 2021.09. 09.459504, 2021 | 17 | 2021 |
| A multi-functional peptide as an HIV-1 entry inhibitor based on self-concentration, recognition, and covalent attachment L Zhao, P Tong, YX Chen, ZW Hu, K Wang, YN Zhang, DS Zhao, LF Cai, ... Organic & biomolecular chemistry 10 (32), 6512-6520, 2012 | 16 | 2012 |
| 10E8-like neutralizing antibodies against HIV-1 induced using a precisely designed conformational peptide as a vaccine prime Y Yu, P Tong, Y Li, ZF Lu, YH Chen Science China Life Sciences 57, 117-127, 2014 | 10 | 2014 |
